Inspira Technologies Oxy B.H.N. (IINNW) Competitors

$0.62
+0.13 (+26.01%)
(As of 05/3/2024 08:52 PM ET)

IINNW vs. AIMDW, BBLGW, DHAIW, COCHW, HSCSW, NXLIW, PAVMZ, PETVW, OSAAW, and MDAIW

Should you be buying Inspira Technologies Oxy B.H.N. stock or one of its competitors? The main competitors of Inspira Technologies Oxy B.H.N. include Ainos (AIMDW), Bone Biologics (BBLGW), DIH Holding US (DHAIW), Envoy Medical (COCHW), Heart Test Laboratories (HSCSW), Nexalin Technology (NXLIW), PAVmed (PAVMZ), PetVivo (PETVW), ProSomnus (OSAAW), and Spectral AI (MDAIW). These companies are all part of the "medical devices" industry.

Inspira Technologies Oxy B.H.N. vs.

Ainos (NASDAQ:AIMDW) and Inspira Technologies Oxy B.H.N. (NASDAQ:IINNW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, risk, institutional ownership, profitability, valuation and community ranking.

Company Net Margins Return on Equity Return on Assets
AinosN/A N/A N/A
Inspira Technologies Oxy B.H.N. N/A N/A N/A

Ainos and Inspira Technologies Oxy B.H.N. both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
AinosN/AN/A
Inspira Technologies Oxy B.H.N.N/AN/A

In the previous week, Inspira Technologies Oxy B.H.N.'s average media sentiment score of 0.00 equaled Ainos'average media sentiment score.

Company Overall Sentiment
Ainos Neutral
Inspira Technologies Oxy B.H.N. Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$122.11KN/AN/AN/AN/A
Inspira Technologies Oxy B.H.N.N/AN/AN/AN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ainos
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Inspira Technologies Oxy B.H.N.
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

Ainos beats Inspira Technologies Oxy B.H.N. on 1 of the 1 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IINNW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IINNW vs. The Competition

MetricInspira Technologies Oxy B.H.N.Medical Devices IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.12B$5.01B$7.72B
Dividend YieldN/A2.36%2.90%3.96%
P/E RatioN/A239.15240.8219.09
Price / SalesN/A241.092,457.9388.31
Price / CashN/A15.1550.1136.12
Price / BookN/A4.324.904.36
Net IncomeN/A$61.33M$104.19M$214.85M
7 Day PerformanceN/A-1.78%3.94%2.26%
1 Month PerformanceN/A-1.96%-3.05%-2.35%
1 Year Performance239.23%55.31%4.22%9.00%

Inspira Technologies Oxy B.H.N. Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AIMDW
Ainos
0 of 5 stars
$0.08
+14.5%
N/AN/A$0.00$122,112.000.0046
BBLGW
Bone Biologics
0 of 5 stars
$23.04
flat
N/AN/A$0.00N/A0.002
DHAIW
DIH Holding US
0 of 5 stars
$0.04
flat
N/AN/A$0.00$55.00M0.00N/A
COCHW
Envoy Medical
0 of 5 stars
$0.17
flat
N/AN/A$0.00$316,000.000.0034
HSCSW
Heart Test Laboratories
0 of 5 stars
$0.04
flat
N/AN/A$0.00$18,600.000.0012
NXLIW
Nexalin Technology
0 of 5 stars
$0.18
flat
N/A+54.6%$0.00$110,748.000.006
PAVMZ
PAVmed
0 of 5 stars
$0.03
-25.0%
N/A-80.9%$0.00$2.45M0.00124Gap Down
PETVW
PetVivo
0 of 5 stars
$0.04
flat
N/AN/A$0.00$1.05M0.0025
OSAAW
ProSomnus
0 of 5 stars
$0.00
flat
N/AN/A$0.00$27.65M0.00136
MDAIW
Spectral AI
0 of 5 stars
$0.15
-0.2%
N/AN/A$0.00$18.06M0.0078

Related Companies and Tools

This page (NASDAQ:IINNW) was last updated on 5/6/2024 by MarketBeat.com Staff

From Our Partners